Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy

Table 1 Baseline characteristics of patients

*Variable*	*Inflammation negative group*		*Inflammation positive group*
*Variable*	Total No. of pts.	Value	Total No. of pts.	Value	p Value
Sex (male/female)	10	8 (80%) / 2 (20%)	22	17 (77%)/5 (33%)	0.863¿
Age (years)	10	46.7 ± 5.87	22	42.36 ± 2.07	0.389
NYHA
II	10	1 (10%)	22	0 (0%)	0.132¿
III	10	7 (70%)	22	15 (68%)	0.918¿
IV	10	2 (20%)	22	7 (32%)	0.491¿
Cardiac parameters
LBBB (%)	10	3 (30%)	22	5 (22.7%)	0.659¿
Permanent AF (%)	10	2 (20%)	22	0 (0%)	0.000¿*
LVEF (%)	10	24.10 ± 2.28	22	23.05 ± 1.35	0.678
LVEDD (cm)	10	6.89 ± 0.17	22	6.89 ± 0.19	0.998
LVEDDI (cm/m2)	10	3.68 ± 0.21	22	3.71 ± 0.09	0.847
Mean Ao (mmHg)	10	92.00 ± 3.95	22	86.06 ± 2.71	0.291
Mean RAP (mmHg)	10	16.22 ± 3.19	22	11.44 ± 1.74	0.164
Mean PCWP (mmHg)	10	25.00 ± 2.79	22	23.45 ± 2.70	0.731
Mean PAP (mmHg)	10	34.89 ± 4.33	22	32.95 ± 3.24	0.734
CI (L/min/m2)	10	2.38 ± 0.33	22	2.2 ± 0.14	0.573

Data are presented as the means ± SE. *Significant at 0.05 level. ¿Chi- square test. Abbreviations: NYHA – New York Heart Association functional class; LBBB – left bundle branch block; AF – atrial fibrillation; LVEF - left ventricular ejection fraction; LVEDD – left ventricular end-diastolic diameter; LVEDDI – left ventricular end-diastolic diameter index; Ao – aortic; RAP – right atrial pressure; PCWP – pulmonary capillary wedge pressure; PAP – pulmonary artery pressure; CI – cardiac index.

ISSN: 1471-2261